Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.

@article{Tenforde2017AdvancedHI,
  title={Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.},
  author={Mark W. Tenforde and Margaret Mokomane and Tshepo B Leeme and Raju K. K. Patel and Nametso Lekwape and Chandapiwa Ramodimoosi and Bonno Dube and Elizabeth A. Williams and Kelebeletse O Mokobela and Ephraim O. Tawanana and Tlhagiso Pilatwe and William J Hurt and Hannah K Mitchell and Doreen L Banda and Hunter Stone and Mooketsi Molefi and Kabelo Mokgacha and Heston E. Phillips and Paul C. Mullan and Andrew P. Steenhoff and Yohana Mashalla and Madisa O Mine and Joseph Nicholas Jarvis},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2017},
  volume={65 5},
  pages={779-786}
}
Background Botswana has a well-developed antiretroviral therapy (ART) program that serves as a regional model. With wide ART availability, the burden of advanced human immunodeficiency virus (HIV) and associated opportunistic infections would be expected to decline. We performed a nationwide surveillance study to determine the national incidence of… CONTINUE READING